Skip to main content

Table 1 Clinicopathological characteristics of all patients

From: Prediction of neoadjuvant chemotherapeutic efficacy in patients with locally advanced gastric cancer by serum IgG glycomics profiling

CharacteristicsTotal (%)Non-response group (%)Response group (%)P value
Age0.884
 ≤ 6025 (51)13 (54)12 (48) 
 > 6024 (49)11 (46)13 (52) 
Sex0.924
 Male34 (69)16 (67)18 (72) 
 Female15 (31)8 (33)7 (28) 
Site0.291
 U11 (22)6 (25)5 (20) 
 M15 (31)8 (33)7 (28) 
 L16 (33)9 (38)7 (28) 
 Overlapping7 (14)1 (4)6 (24) 
Histology0.479
 Adenocarcinoma11 (22)4 (17)7 (28) 
 SRC6 (12)4 (17)2 (8) 
 Other32 (65)16 (67)16 (64) 
Regimen0.686
 DOS10 (20)6 (25)4 (16) 
 XELOX23 (47)11 (46)12 (48) 
 Other16 (33)5 (21)8 (32)